U
FURX

UBS’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

UBS’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,149
Closed -$546K – 11355
2014
Q2 		$546K Buy
5,149
+4,910
+2,054% +$482K ﹤0.01% 4150
2014
Q1 		$21K Sell
239
-5,763
-96% -$445K ﹤0.01% 8052
2013
Q4 		$252K Buy
6,002
+5,960
+14,190% +$245K ﹤0.01% 5048
2013
Q3 		$2K Hold
42
– – ﹤0.01% 10073
2013
Q2 		$1K Buy
+42
New +$1.47K ﹤0.01% 10121

UBS's FURX Position: Q3 2014 in Review

UBS sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 5,149 shares — an estimated $546K sold.

UBS first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $546K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • UBS reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • UBS sold 5,149 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $546K.
  • UBS first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • UBS's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $546K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.